(Sharecast News) - London stocks were set to edge lower at the open on Monday following a downbeat session in Asia. The FTSE 100 was called to open down around 15 points.
A 2023 assessment of Beisa North and South reported an upside value of ZAR2.3 billion for 46.02 million pounds of uranium, Neo Energy said. This was based on around 51% of the prospect's total ...
(Alliance News) - Ireland's service sector economy ended the year strongly, though the pace of its expansion eased slightly, numbers on Monday showed. The AIB services business activity index faded to ...
The pound was quoted at USD1.2443 early Monday in London, up from USD1.2414 at the time of the London equities close on Friday. The euro rose to USD1.0311 from USD1.0297. Against the yen, the dollar ...
(Alliance News) - Last year was one of the quietest on record for the London Stock Exchange, which saw the largest outflow of companies since the global financial crisis, stark new analysis shows.
(Sharecast News) - London stock markets closed in the red on Friday as sharp declines in airline, mining, and housebuilding stocks weighed on indices, with a lack of significant news and profit-taking ...
(Alliance News) - US President-elect Donald Trump called on Friday for the UK to dismantle its wind turbines in the North Sea in response to a decision by a US oil company to leave the oil-rich region ...
Through its Croatian subsidiary, IGeoPen doo, A14 Energy owns three geothermal waters exploration licences in the Pannonian Basin in Croatia.
The Tanzania-focused helium exploration company noted Blue Star Helium's release which said works have started on site access and the well pad at Jackson #31, where drilling is expected to start in ...
(Alliance News) - Aptamer Group PLC on December 19 said it signed a new development contract with a rare disease biopharmaceutical company. The York, England-based biotechnology firm providing Optimer ...
Volex said the acquisition has exceeded earnings before interest, tax, depreciation and amortisation targets set in the acquisition agreement during the first 12 months. Therefore, the company will ...
(Alliance News) - GSK PLC on Friday reported that its Nucala treatment has been approved in China to treat long-term sufferers of a sinus ailment following a phase 3 study.